Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT03047993
Title Glutaminase Inhibitor CB-839 and Azacitidine in Treating Patients With Advanced Myelodysplastic Syndrome
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements Yes
Sponsors M.D. Anderson Cancer Center

chronic myelomonocytic leukemia

myelodysplastic syndrome


Azacitidine + Telaglenastat

Age Groups: adult | senior
Covered Countries USA

Additional content available in CKB BOOST